CAS 217813-15-5

Formule : C37H39ClN4O5S

InChI : InChI=1S/C37H39ClN4O5S/c1-39(2)20-25-42-32-10-6-4-8-30(32)35(36(42)37(44)41-23-21-40(22-24-41)33-11-7-5-9-31(33)38)34(26-12-16-28(43)17-13-26)27-14-18-29(19-15-27)47-48(3,45)46/h4-19,34,43H,20-25H2,1-3H3

Code InChI : SUJJACDTWCALRH-UHFFFAOYSA-N

SMILES : CN(C)CCN1C2=CC=CC=C2C(=C1C(=O)N3CCN(CC3)C4=CC=CC=C4Cl)C(C5=CC=C(C=C5)O)C6=CC=C(C=C6)OS(=O)(=O)C

KW-8232

CAS : 217813-15-5

KW-8232

Formule : C₃₇H₄₁ClN₄O₆S

Degré de pureté : 98.02%

Masse moléculaire : 705.26

Ref: 54-OR1110371

KW-8232

CAS : 217813-15-5

Degré de pureté : 98.02%

Ref: IN-DA01V7G9

KW-8232

CAS : 217813-15-5

KW-8232 is an inhibitor of the protein kinase C (PKC) enzyme. The PKC family of enzymes plays a key role in many cellular processes, such as cell proliferation, differentiation, and apoptosis. KW-8232 has been shown to inhibit PKC activity by binding to the ATP-binding site on PKC and blocking the phosphorylation of its substrate proteins. KW-8232 is used as a research tool for studies of PKC and other protein kinases.

Formule : C₃₇H₃₉ClN₄O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 687.2 g/mol

Ref: 3D-SIA81315

KW-8232

CAS : 217813-15-5

KW-8232, an orally active anti-osteoporotic agent, reduces the biosynthesis of PGE2[1].

Formule : C₃₇H₄₁ClN₄O₆S

Couleur et forme : Solid

Masse moléculaire : 705.27

Ref: TM-T36762